The high-tech screening for diabetic retinopathy has already been added to five grocery stores in Delaware and Pennsylvania. Medscape Medical News
Author: Medscape
Peripheral Fields Key in Predicting Diabetic Retinopathy
A new artificial intelligence algorithm uses peripheral retinal field images to predict how quickly diabetic retinopathy will progress and which patients need immediate attention. Medscape Medical News
Public Commenting Has Been Hijacked by Biopharma
In a recent analysis, 1 in 2 ‘public commenters’ giving input on state-level drug coverage decisions was someone with financial ties to the pharmaceutical industry. Medscape Oncology
FDA OKs First Contact Lens to Slow Myopia in Children
MiSight (CooperVision Inc) soft, disposable contact lenses are meant to be worn daily (but not overnight) to correct nearsightedness and slow the progression of myopia in children 8 to 12 years old. FDA Approvals
Solving a Medical Mystery Crucial to Future Space Travel
Half the astronauts on the International Space Station have been held back by blurry vision, jeopardizing longer missions to Mars, and clinicians are racing to prevent the perplexing problem. Medscape Medical News
Double Trouble: 4 Things to Do in Patients With Diplopia
A guide for discerning whether the cause of new-onset diplopia is benign or potentially life-threatening. Medscape Ophthalmology
Snubbed by Scientists, Recognized 20 Years Later
Robert Folberg’s success was 2 decades in the making after his team discovered vasculogenic mimicry. Their original report received a frosty reception, but has since been cited more than 1900 times. Medscape Medical News
Teprotumumab Improves Bulging, QOL, in Thyroid Eye Disease
The pooled results of phase 2 and 3 clinical trials could pave the way for first approved drug for thyroid eye disease. Medscape Medical News
Teprotumumab Improves Bulging, QOL in Thyroid Eye Disease
The pooled results of phase 2 and 3 clinical trials could pave the way for first approved drug for thyroid eye disease. Medscape Medical News
Further Debate on T3 + T4 Combination Therapy at ATA Meeting
The 89th annual meeting gets underway this week, with anaplastic thyroid cancer guidelines and combination T3 /T4 therapy among the highlights being discussed. Medscape Medical News
Hitting the Effective Lens Position Target in Cataract Surgery
Dr Sumit (Sam) Garg comments on a new study using prediction errors in the first eye to refine refractive outcomes in the second eye. Medscape Ophthalmology
More Evidence Links Common Bladder Drug to Retinal Damage
Pentosan polysulfate sodium (PPS), used widely for interstitial cystitis, may lead to retinal damage, according to a new study that adds weight to this previously suggested link. Reuters Health Information
Intraocular Trifocals Outdo Extended Depth for Near Vision
Trifocal lenses offer better near vision than extended depth of focus lenses, a head-to-head study shows. Medscape Medical News
Postoperative Adjustment of Intraocular Lenses Holds Promise
When ophthalmologists calculate intraocular lens power for cataract surgery patients, they should consider the cornea, but postoperatively adjustable lenses could be the way of the future. Medscape Medical News
Lens Adjustment After Cataract Surgery in View
When specialists calculate intraocular lens power for patients undergoing cataract surgery, they should consider the cornea, but postoperatively adjustable lenses could be the way of the future. Medscape Medical News
Unexpected Cause of Myopathy in Sjogren’s: Crack the Case
Dr Paget reminds us to keep non-autoimmune-related causes of muscle enzyme level elevation in mind when diagnosing a patient. Medscape Rheumatology
AI Sparks Legal Debate Over Machine-Generated Mistakes
Specialists are figuring out where computers belong in the healthcare system, how reimbursement will work, and who is legally liable when machines make mistakes. Medscape Medical News
Treat Corneal Irregularities Before Cataract Surgery
Dr Christopher Rapuano comments on a new study showing that appropriately managing common corneal surface irregularities can greatly aid in improving refractive outcomes after cataract surgery. Medscape Ophthalmology
AAO 2019
Read clinically focused news coverage of key developments from AAO 2019 Medscape Ophthalmology
FDA Approves New Injection Brolucizumab (Beovu ) for Wet AMD
The US Food and Drug Administration approved brolucizumab (Beovu, Novartis) injection for wet age-related macular degeneration (AMD). FDA Approvals